Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension

BACKGROUND: This study investigates the long-term efficacy and safety of evogliptin add-on therapy in patients with inadequately controlled type 2 diabetes mellitus (T2DM) previously received dapagliflozin and metformin (DAPA/MET) combination. METHODS: In this multicenter randomized placebo-controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Jun Sung, Park, Il Rae, Kim, Hae Jin, Chung, Choon Hee, Won, Kyu Chang, Han, Kyung Ah, Park, Cheol-Young, Won, Jong Chul, Kim, Dong Jun, Koh, Gwan Pyo, Kim, Eun Sook, Yu, Jae Myung, Hong, Eun-Gyoung, Lee, Chang Beom, Yoon, Kun-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695708/
https://www.ncbi.nlm.nih.gov/pubmed/37750183
http://dx.doi.org/10.4093/dmj.2022.0387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695708/
https://www.ncbi.nlm.nih.gov/pubmed/37750183
http://dx.doi.org/10.4093/dmj.2022.0387

Ejemplares similares